Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 9/2017

01-09-2017 | Original Article

Interval Magnetic Resonance Imaging: an Alternative to Guidelines for Indeterminate Nodules Discovered in the Cirrhotic Liver

Authors: Eliza W. Beal, Joseph F. Kearney, Jeffery M. Chakedis, A. James Hanje, Lanla F. Conteh, Sylvester M. Black, Kenneth Washburn, Kristin M. Dittmar, Timothy M. Pawlik, Mary R. Dillhoff, Carl R. Schmidt

Published in: Journal of Gastrointestinal Surgery | Issue 9/2017

Login to get access

Abstract

Background

Current guidelines for the management of indeterminate nodules discovered on surveillance imaging recommend alternate imaging modality or biopsy. This study evaluates the use of short interval MRI rather than immediate CT or biopsy.

Method

This retrospective cohort study examines outcomes of 111 patients with indeterminate nodules reviewed by a single institution’s Liver Tumor Board 2011–2016. Analysis was focused on outcomes stratified by management decision.

Results

The tumor board recommended biopsy or immediate repeat CT imaging in 13 (12%), 3-month interval MRI in 64 (58%) and 6-month interval MRI for 34 (30%) patients. Twenty-eight (29%) patients in the interval MRI subgroups were diagnosed with hepatocellular carcinoma (HCC) during the period of follow-up, and 21 (75%) of these were located within the original indeterminate nodule. The median time to diagnosis was 6.5 months. Twenty-three (82%) were eligible for potentially curative therapy at the time of HCC diagnosis. Delay in HCC diagnosis was not the reason for inability to provide potentially curative therapy in any patient.

Conclusion

This study supports the judicious use of interval MRI at 3 or 6 months in patients with liver cirrhosis and an indeterminate liver nodule rather than immediate CT scan or biopsy.
Literature
1.
go back to reference CDC. Hepatocellular Carcinoma --- United States, 2001--2006: Centers for Disease Control and Prevention; 2010 CDC. Hepatocellular Carcinoma --- United States, 2001--2006: Centers for Disease Control and Prevention; 2010
3.
go back to reference Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004 Jul;130(7):417–22.CrossRefPubMed Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004 Jul;130(7):417–22.CrossRefPubMed
4.
go back to reference Cruite I, Tang A, Sirlin CB. Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol. 2013 Jul;201(1):41–55.CrossRefPubMed Cruite I, Tang A, Sirlin CB. Imaging-based diagnostic systems for hepatocellular carcinoma. AJR Am J Roentgenol. 2013 Jul;201(1):41–55.CrossRefPubMed
5.
go back to reference Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009 Apr;7(4):350–91.CrossRefPubMedPubMedCentral Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009 Apr;7(4):350–91.CrossRefPubMedPubMedCentral
6.
7.
go back to reference Beal EW, Albert S, McNally M, Shirley LA, Hanje J, Michaels AJ, et al. An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy. J Surg Oncol. 2014 Dec;110(8):967–9.CrossRefPubMedPubMedCentral Beal EW, Albert S, McNally M, Shirley LA, Hanje J, Michaels AJ, et al. An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy. J Surg Oncol. 2014 Dec;110(8):967–9.CrossRefPubMedPubMedCentral
8.
9.
go back to reference Adkisson CD, Sibulesky L, Collis GN, McLaughlin DW, Oldenburg WA, Nguyen JH. Aneurysmectomy and revascularization of a large hepatic artery aneurysm. Ann Vasc Surg. 2011 May;25(4):556.e11–5.CrossRef Adkisson CD, Sibulesky L, Collis GN, McLaughlin DW, Oldenburg WA, Nguyen JH. Aneurysmectomy and revascularization of a large hepatic artery aneurysm. Ann Vasc Surg. 2011 May;25(4):556.e11–5.CrossRef
10.
go back to reference Van Petersen A, Meerwaldt R, Geelkerken R, Zeebregts C. Surgical options for the management of visceral artery aneurysms. J Cardiovasc Surg (Torino). 2011 Jun;52(3):333–43.PubMed Van Petersen A, Meerwaldt R, Geelkerken R, Zeebregts C. Surgical options for the management of visceral artery aneurysms. J Cardiovasc Surg (Torino). 2011 Jun;52(3):333–43.PubMed
11.
go back to reference Abbas MA, Fowl RJ, Stone WM, Panneton JM, Oldenburg WA, Bower TC, et al. Hepatic artery aneurysm: factors that predict complications. J Vasc Surg. 2003 Jul;38(1):41–5.CrossRefPubMed Abbas MA, Fowl RJ, Stone WM, Panneton JM, Oldenburg WA, Bower TC, et al. Hepatic artery aneurysm: factors that predict complications. J Vasc Surg. 2003 Jul;38(1):41–5.CrossRefPubMed
12.
go back to reference Huang Y, Banga P, Reis De Souza L, Oderich GS. Endovascular treatment of visceral artery aneurysms. J Cardiovasc Surg (Torino). 2015 Aug;56(4):567–77. Huang Y, Banga P, Reis De Souza L, Oderich GS. Endovascular treatment of visceral artery aneurysms. J Cardiovasc Surg (Torino). 2015 Aug;56(4):567–77.
13.
go back to reference Grotemeyer D, Grabitz K, Balzer K, Reinecke P, Poll L, Sandmann W. [Mycotic visceral artery aneurysm: clinical picture, diagnosis, differential therapy, and discussion of the literature]. Chirurg. 2004 May;75(5):533–40.CrossRefPubMed Grotemeyer D, Grabitz K, Balzer K, Reinecke P, Poll L, Sandmann W. [Mycotic visceral artery aneurysm: clinical picture, diagnosis, differential therapy, and discussion of the literature]. Chirurg. 2004 May;75(5):533–40.CrossRefPubMed
14.
go back to reference Bürger T, Halloul Z, Meyer F, Grote R, Lippert H. Emergency stent-graft repair of a ruptured hepatic artery secondary to local postoperative peritonitis. J Endovasc Ther. 2000 Aug;7(4):324–7.CrossRefPubMed Bürger T, Halloul Z, Meyer F, Grote R, Lippert H. Emergency stent-graft repair of a ruptured hepatic artery secondary to local postoperative peritonitis. J Endovasc Ther. 2000 Aug;7(4):324–7.CrossRefPubMed
15.
go back to reference Kadohama T, Ohtani N, Sasajima T. Hepatic artery aneurysm involving the proper hepatic and gastroduodenal artery treated using a gastroepiploic artery in situ bypass. J Vasc Surg. 2007 May;45(5):1069–71.CrossRef Kadohama T, Ohtani N, Sasajima T. Hepatic artery aneurysm involving the proper hepatic and gastroduodenal artery treated using a gastroepiploic artery in situ bypass. J Vasc Surg. 2007 May;45(5):1069–71.CrossRef
16.
go back to reference Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging—a systematic review and meta-analysis. Radiology. 2015 Apr;275(1):97–109.CrossRefPubMed Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging—a systematic review and meta-analysis. Radiology. 2015 Apr;275(1):97–109.CrossRefPubMed
17.
go back to reference Lu NN, Huang Q, Wang JF, Wei BJ, Gao K, Zhai RY. Treatment of post-liver transplant hepatic artery pseudoaneurysm with balloon angioplasty after failed stent graft placement. Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):e109–13.CrossRefPubMed Lu NN, Huang Q, Wang JF, Wei BJ, Gao K, Zhai RY. Treatment of post-liver transplant hepatic artery pseudoaneurysm with balloon angioplasty after failed stent graft placement. Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):e109–13.CrossRefPubMed
18.
go back to reference Goldberg DS, Valderrama A, Kamalakar R, Sansgiry SS, Babajanyan S, Lewis JD. Hepatocellular carcinoma surveillance among cirrhotic patients with commercial health insurance. J Clin Gastroenterol. 2016 Mar;50(3):258–65.CrossRefPubMed Goldberg DS, Valderrama A, Kamalakar R, Sansgiry SS, Babajanyan S, Lewis JD. Hepatocellular carcinoma surveillance among cirrhotic patients with commercial health insurance. J Clin Gastroenterol. 2016 Mar;50(3):258–65.CrossRefPubMed
19.
go back to reference Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015 Nov;13(12):2140–51.CrossRefPubMedPubMedCentral Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol. 2015 Nov;13(12):2140–51.CrossRefPubMedPubMedCentral
Metadata
Title
Interval Magnetic Resonance Imaging: an Alternative to Guidelines for Indeterminate Nodules Discovered in the Cirrhotic Liver
Authors
Eliza W. Beal
Joseph F. Kearney
Jeffery M. Chakedis
A. James Hanje
Lanla F. Conteh
Sylvester M. Black
Kenneth Washburn
Kristin M. Dittmar
Timothy M. Pawlik
Mary R. Dillhoff
Carl R. Schmidt
Publication date
01-09-2017
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 9/2017
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3454-6

Other articles of this Issue 9/2017

Journal of Gastrointestinal Surgery 9/2017 Go to the issue